Top Page
Target Healthcare REIT
(LSE:THRL)
Target Healthcare REIT (THRL) vs. S&P 500 (SPY)
Target Healthcare REIT Business Overview & Revenue Model
Target Healthcare REIT Financial Statement Overview
| Breakdown | ||||
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 69.55M | 67.75M | 63.86M | 49.98M | 44.27M | Gross Profit |
| 61.83M | 60.14M | 56.55M | 44.18M | 39.00M | EBIT |
| 58.00M | 57.01M | 50.16M | 38.85M | 34.74M | EBITDA |
| 58.00M | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
| 73.02M | -6.57M | 49.10M | 43.88M | 31.62M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 38.88M | 19.66M | 34.48M | 21.11M | 36.44M | Total Assets |
| 967.37M | 908.26M | 963.66M | 718.39M | 663.77M | Total Debt |
| 240.67M | 227.05M | 231.38M | 127.90M | 150.13M | Net Debt |
| -38.88M | 210.01M | 197.36M | 108.57M | 133.59M | Total Liabilities |
| 278.08M | 253.45M | 264.89M | 153.21M | 169.66M | Stockholders Equity |
| 689.29M | 654.81M | 698.77M | 565.18M | 494.11M |
| Cash Flow | Free Cash Flow | |||
| 42.34M | 29.66M | 30.39M | 24.96M | 21.47M | Operating Cash Flow |
| 42.34M | 29.66M | 30.39M | 24.96M | 21.47M | Investing Cash Flow |
| 3.42M | -3.55M | -202.63M | -43.58M | -103.42M | Financing Cash Flow |
| -22.24M | -45.23M | 185.62M | 3.29M | 91.44M |
Target Healthcare REIT Technical Analysis
Target Healthcare REIT Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | 8.02 | 10.58% | 5.96% | 4.41% | 23.70% | ||
74 Outperform | £1.35B | 32.68 | 2.96% | 6.81% | 7.01% | 51.96% | |
71 Outperform | £600.25M | 15.86 | 4.48% | 4.10% | 4.60% | -35.59% | |
69 Neutral | £161.59M | 17.86 | 5.56% | 7.84% | ― | ― | |
61 Neutral | £129.34M | ― | -3.67% | 3.07% | 35.36% | -153.97% | |
59 Neutral | $2.72B | 11.53 | 0.09% | 8679.99% | 5.56% | -16.50% | |
51 Neutral | ― | 1.82% | ― | ― |
Target Healthcare REIT Corporate Events
Target Healthcare REIT PLC announced a change in its voting rights structure following an acquisition or disposal by Waverton Investment Management Limited. The notification indicates that Waverton now holds 3.04% of the voting rights, totaling 18,869,630 shares, which may impact the company’s governance and decision-making processes.
Spark’s Take on GB:THRL Stock
According to Spark, TipRanks’ AI Analyst, GB:THRL is a Outperform.
Target Healthcare REIT demonstrates strong financial performance and valuation metrics, with a stable dividend yield and attractive P/E ratio. The technical analysis suggests positive momentum, though caution is advised due to overbought indicators. Recent corporate activities further support a positive sentiment, positioning the company well for future growth.
To see Spark’s full report on GB:THRL stock, click here.
Target Healthcare REIT PLC announced a live presentation of its Interim Results by Kenneth MacKenzie and James MacKenzie from Target Fund Managers. The presentation, scheduled for 1 April 2025, is accessible to all existing and potential shareholders, allowing them to engage and submit questions. This initiative aims to enhance transparency and engagement with stakeholders, potentially impacting investor relations positively.
Target Healthcare REIT plc reported a strong performance for the six months ending December 2024, with a 1.8% increase in EPRA NTA per share and a 4.5% total accounting return. The company has maintained a robust balance sheet with long-term fixed-rate debt and a fully covered growing dividend. The portfolio’s market valuation rose by 1.8%, driven by rental uplifts and capital expenditure, while maintaining a high occupancy rate and strong rent collection. The company benefits from sectoral tailwinds such as an aging population and a trend towards quality care homes, positioning it well for future growth.
Target Healthcare REIT announced it will release its half-year results for the period ending 31 December 2024 on 14 March 2025. The company emphasizes its strategy of building supportive relationships with tenants to enhance care standards and ensure stable returns, reflecting its commitment to sustainable business practices.
Target Healthcare REIT has appointed Panmure Liberum Limited as a joint broker alongside its existing corporate broker, Stifel Nicolaus Europe Limited. This strategic move is expected to enhance the company’s market operations and potentially strengthen its industry positioning by leveraging the expertise of both brokers.
Target Healthcare REIT PLC has announced that BlackRock, Inc. has increased its holdings in the company, crossing the 5% threshold of voting rights. This acquisition by a major global investment firm like BlackRock could signal confidence in Target Healthcare’s market position and potential for growth, potentially impacting investor sentiment positively.
The notification indicates that BlackRock, Inc. has adjusted its holdings in Target Healthcare REIT PLC, with its voting rights now falling below 5%. This change reflects BlackRock’s ongoing portfolio management strategy and may influence the market perception of Target Healthcare REIT’s stock, potentially affecting investor sentiment and trading activity.
Target Healthcare REIT announced a 0.9% increase in its EPRA Net Tangible Assets per share, driven by inflation-linked rent reviews, and declared a second interim dividend. The company maintains a positive outlook due to demographic trends and demand for modern care homes, with a stable rent cover and strong tenant base supporting its long-term returns.